Russia will test the “Sputnik V” and AstraZeneca combination vaccine in Ukraine.

Reuters reported on January 3 that the head of the Russian Direct Investment Fund (RDIF) said on the 2nd that Russia is preparing to conduct a clinical trial of the novel coronavirus vaccine in Ukraine, which combines the Russian “Sputnik V ” vaccine and the vaccine jointly developed by AstraZeneca and Oxford University.

The Russian Direct Investment Fund, which is currently selling “Sputnik V ” vaccines abroad, announced in December that it will test the combination of AstraZeneca vaccine and “Sputnik V ” vaccine to see if it can improve its effectiveness.